Novartis Pharma AG, CH-4002 Basel, Switzerland. www.novartis.com© April 2020 Novartis Pharma AG | GLNS/AMG/0582b May 2020Novartis processes personal data in accordance with the Personal Information Act and GDPR. We respect your rights to access the personal information stored about you. You have the right to request correcting or deleting of such information, as well as requesting the removal of personal data about you. Please contact global.privacy_office@novartis.com

Saturday, 23 May 2020, 13:45 – 14:45, CEST

EAN virtual congress: www.eanvirtualcongress.org

Room name: Vienna

This virtual Satellite Symposium at the 6th EAN Congress 2020 is sponsored by Novartis and chaired by Professor Patricia Pozo-Rosich (Vall d’Hebron University Hospital, Barcelona, Spain). Join us to discuss the challenges in maintaining migraine management at this time of a global health crisis and the potential to turn this crisis into an opportunity to improve future patient care. The role of migraine prevention as a potential tool to alleviate some of the resource constraints will be discussed, and our esteemed faculty will also be providing some practical information and advice on how to maintain continuity of care during these difficult times.

6th Congress of the European Academy of Neurology

Maintaining migraine management during times of a global health crisis

On-demand webcasts: Available to all congress registrants from 23 – 26 May and to all EAN members from 27 May 2020 onwards

Congress content will also be available free-of-charge to all neurologists from 11 – 14 July 2020

Novartis Pharma AG, CH-4002 Basel, Switzerland. www.novartis.com© April 2020 Novartis Pharma AG | GLNS/AMG/0582b May 2020Novartis processes personal data in accordance with the Personal Information Act and GDPR. We respect your rights to access the personal information stored about you. You have the right to request correcting or deleting of such information, as well as requesting the removal of personal data about you. Please contact global.privacy_office@novartis.com

Novartis is responding to COVID-19 with the safety of our associates and patients globally being our primary concern. We are also contributing to research efforts, supporting communities, and

ensuring a stable supply and price of essential medicines.

Short-term challenges and longer-term opportunitiesPatricia Pozo-Rosich (Vall d’Hebron University Hospital, Barcelona, Spain)

The burden of migraine and the need for continuous and consistent managementPascal Proot (Ghent University Hospital, Ghent, Belgium)

Adapting to the current reality of migraine management in EuropeAndreas Gantenbein (RehaClinic, Bad Zurzach, Switzerland)

Migraine prevention: Experience from the US and implications for the current crisisStewart J Tepper (Dartmouth-Hitchcock Medical Center, New Hampshire, United States)

What are patients with migraine asking? A practical discussion with the panelModerated by Patricia Pozo-Rosich

Ensuring a positive legacy for our patientsPatricia Pozo-Rosich (Vall d’Hebron University Hospital, Barcelona, Spain)

Maintaining migraine management during times of a global health crisis Come and explore

our virtual exhibition booth and visit our eposters

to see how Novartis is reimagining medicine